Table 1.
Patient demographics (N = 307).
| Disease Type |
N | Period to Exam. (Months) |
Age (y) |
Sex (M/F) |
IVO Test | T&T Test | |||
|---|---|---|---|---|---|---|---|---|---|
| Response (Yes/No) |
Latency (s) |
Duration (s) |
Response (Yes/No) |
Recognition Score | |||||
| PVOD | 118 | 3.0 ± 1.5 | 54.1 ± 12.5 | M: 26 (22%) F: 92 (78%) |
58 (49%) /60 (51%) |
22.1 ± 10.5 | 71.3 ± 46.9 | 102 (86%) /16 (14%) |
3.6 ± 1.7 |
| CRS with polyps |
117 | n.d. | 54.4 ± 10.2 | M: 79 (68%) F: 38 (32%) |
95 (81%) /22 (19%) |
18.9 ± 7.8 | 66.9 ± 35.3 | 69 (59%) /48 (41%) |
4.4 ± 1.5 |
| CRS without polyps |
44 | n.d. | 52.1 ± 9.2 | M: 30 (68%) F: 14 (32%) |
39 (89%) /5 (11%) |
15.5 ± 7.9 | 80.6 ± 51.8 | 37 (84%) /7 (16%) |
3.3 ± 1.7 |
| PTOD | 28 | 3.0 ± 1.6 | 46.3 ± 12.6 | M: 14 (50%) F: 14 (50%) |
12 (43%) /16 (57%) |
17.3 ± 7.3 | 55.9 ± 30.4 | 11 (39%) /17 (61%) |
5.2 ± 1.1 |
PVOD, post-viral olfactory dysfunction; PTOD, post-traumatic olfactory dysfunction; CRS, chronic rhinosinusitis; w/o, without; N, number of cases; Exam., examination; n.d., not determined; M, male; F, female.